James Noble

James Noble

Chairman at
Celleron Therapeutics Ltd.

Net worth: 218 278 $ as of 2026-01-30

66 year
Health Technology
Finance
Distribution Services

Profile

James Julian Noble founded Adaptimmune Ltd. in 2008, where he worked as Chief Executive Officer from 2008 to 2014, Adaptimmune Therapeutics Plc in 2008, where he worked as Non-Executive Director from 2019 to 2023, and Immunocore Holdings Plc in 2008, where he worked as Non-Executive Director from 2014 to 2015.
Mr. Noble also currently works at Celleron Therapeutics Ltd., as Chairman, Pneumagen Ltd., as Non-Executive Chairman from 2023, Sutura Therapeutics Ltd., as Chairman, and various other companies.
Mr. Noble also formerly worked at Avidex Ltd., as Chairman & Chief Executive Officer from 2000 to 2014, AfriAg Global Plc, as Non-Executive Chairman from 2010 to 2012, GW Pharmaceuticals Ltd., as Deputy Chairman from 2007 to 2021, and various other companies.
Mr. Noble received his graduate degree in 1980 from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-06-04 64,516 ( 0.19% ) 218 278 $ 2026-01-30

James Noble active positions

CompaniesPositionStart
Chairman -
Chairman -
Chairman 2023-01-05
Chairman -
Director/Board Member 2022-12-31

Former positions of James Noble

CompaniesPositionEnd
LAVA THERAPEUTICS N.V. Director/Board Member 2025-11-06
OREXO AB Chairman 2025-05-07
ADAPTIMMUNE THERAPEUTICS PLC Founder 2023-05-31
GW PHARMACEUTICALS PLC Director/Board Member 2021-05-04
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of James Noble's experience

Training of James Noble

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

39

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies39

Health Technology

Health Technology

Distribution Services

Finance

Health Technology

Finance

Distribution Services

Miscellaneous

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Consumer Non-Durables

Adprotech Pharmaceuticals, Inc.

Health Services

Kleinwort Benson Ltd. (New York)